本页面由Tiger Trade Technology Pte. Ltd.提供服务

Artiva Biotherapeutics, Inc.

11.52
+0.59005.40%
盘前11.45-0.0700-0.61%05:45 EDT
成交量:30.72万
成交额:347.10万
市值:5.63亿
市盈率:-3.59
高:11.70
开:10.83
低:10.49
收:10.93
52周最高:14.53
52周最低:2.22
股本:4,888.58万
流通股本:1,989.95万
量比:1.01
换手率:1.54%
股息:- -
股息率:- -
每股收益(TTM):-3.2084
每股收益(LYR):-3.4309
净资产收益率:-36.58%
总资产收益率:-22.34%
市净率:1.62
市盈率(LYR):-3.36

数据加载中...

公司资料

公司名字:
Artiva Biotherapeutics, Inc.
交易所:
NASDAQ
成立时间:
2019
员工人数:
115
公司地址:
5505 Morehouse Drive,Suite 100,San Diego,California,United States
邮编:
92121
电话:
传真:
- -
简介:
Artiva Biotherapeutics, Inc.于2019年2月14日在特拉华州注册成立。该公司是一家临床阶段的生物技术公司,专注于为患有破坏性自身免疫性疾病和癌症的患者开发基于自然杀伤(NK)细胞的疗法。

董事

名称
职位
Fred Aslan
Director,Chief Executive Officer,Principal Accounting Officer and Principal Financial Officer
Alison Moore
Independent Director
Brian Daniels
Chairperson of the Board and Independent Director
Daniel Baker
Independent Director
Elaine Sorg
Independent Director
Elizabeth Hougen
Independent Director
Laura Stoppel
Independent Director

股东

名称
职位
Fred Aslan
Director,Chief Executive Officer,Principal Accounting Officer and Principal Financial Officer
Jennifer Bush
Chief Operating Officer, Chief Legal Officer and Compliance Officer
Christopher P. Horan
Chief Technical Operations Officer
Diego Miralles
President and Head of Research and Development
Subhashis Banerjee
Chief Medical Officer